New study testing feasibility of remote data collection for ALS trials
Is it feasible to remotely collect health data from people with amyotrophic lateral sclerosis (ALS)? And would doing so…
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Is it feasible to remotely collect health data from people with amyotrophic lateral sclerosis (ALS)? And would doing so…
Continuing its annual support, BluSky Restoration Contractors has raised $140,000 to advance research at the Miller Laboratory at…
Cytokinetics is calling for proposals from patient advocacy organizations focused on amyotrophic lateral sclerosis (ALS) and cardiovascular conditions…
A new Canadian initiative seeks to advance development of an artificial intelligence (AI) program aimed at helping healthcare professionals detect…
Having a family member with amyotrophic lateral sclerosis (ALS) can strain household finances as well as the emotions of…
A new two-year, $400,000 grant will support studies — by EverythingALS and the Sean M. Healey and AMG…
Some $2 million in new grants from two U.S. nonprofits are seeking to help scientists globally to find ways to…
Mitsubishi Tanabe Pharma Canada (MTP-CA) is teaming up with the Canadian Neuromuscular Disease Registry (CNDR) in Canada’s first…
The axeALS Foundation is inviting people in the U.S. with amyotrophic lateral sclerosis (ALS) and demonstrable financial needs…
With an aim to share expertise and diminish duplicative research and care efforts in amyotrophic lateral sclerosis (ALS), two…